Drug price regulator NPPA has given pharma firms time till Friday to register for online database with 19 out of top 100 drug makers yet to respond after repeated reminders.
National Pharmaceutical Pricing Authority (NPPA) had asked all pharma firms to register themselves with Integrated Pharmaceutical Database Management System (IPDMS) in September last year.
The list of 19 companies which have not registered include IPCA Labs, IndSwift Laboratories and Dabur India, among others.
In a letter to companies, NPPA gave "a final opportunity" to the companies to register under IPDMS before June 5, 2015 "or explain the reasons for not registering by making personal appearance before Member Secretary."
On May 1 and May 19, the NPPA had reminded the drug makers to register under the IPDMS for online filing of returns for monitoring, fixing and revision of drug prices.
It had said that availability of reliable database is a necessary pre-requisite for carrying out the functions of price fixation and price revision in respect of scheduled drugs and price fixation in respect of new drugs.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.